Brazil’s Health Surveillance Agency (Anvisa) has given the inexperienced mild to the AstraZeneca/Oxford University and Chinese-made Sinovac Coronavirus vaccines, paving the way in which for the Latin American nation to kickstart the immunisation programme.
Shortly after the unanimous vote to authorise the emergency use of the vaccines, a 54-year-old nurse from Sao Paolo, Monica Calazans turned the primary individual to get the CoronaVac jab.
The nation’s President, Jair Bolsonaro has confronted acute criticism over his dealing with of the pandemic, as he has been enjoying down the virus from the start, and though he caught Coronavirus, he has acknowledged he is not going to take the COVID-19 vaccine.
Sao Paulo Governor and Bolsonaro’s potential political rival within the 2022 presidential elections, Joao Doria hailed the vaccination, saying marks a “historical day” for Brazilian science.
“Science’s victory. Victory of life. Victory in Brazil,” Doria wrote in a Twitter publish.
Dia histórico para ciência brasileira. A Anvisa acaba de aprovar por maioria o uso emergencial da Vacina do Butantan. Vitória da ciência. Vitória da vida. Vitória do Brasil. #VacinaJá pic.twitter.com/DJiVmc00no
— João Doria (@jdoriajr) January 17, 2021
Brazil is one of many nations worst-hit by the Coronavirus pandemic, reporting the second-highest loss of life toll from COVID-19 worldwide, after the US. The nation has to this point recorded almost 8.5 million Coronavirus instances and over 200,000 deaths.